Next Generation Tools for Onsite Monitoring and Treatment of Drug Abuse-Dependent Persons

Brief description of study

The purpose of this study is to see how well an experimental drug test can detect and measure the presence and levels in saliva of seven (7) drugs: buprenorphine, morphine, oxycodone, methadone, heroin, fentanyl, and cocaine. “Experimental” means the test has not been approved or cleared by the US Food and Drug Administration (FDA).

Clinical Study Identifier: s19-01754
Principal Investigator: Joshua D Lee.
Other Investigator: John McDevitt.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.